Opsens Receives dPR Clearance from the FDA Product approval will bolster U.S. commercial efforts Quebec City, Quebec, December 19, 2019 – Opsens Inc. (“Opsens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) announces 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) […]
Month: December 2019
VISIT OPSENS AT SCAI FALL FELLOWS 2019
Learn more about the benefits of OptoWire® as a pressure guidewire to diagnose and treat with confidence at the SCAI Fall Fellows 2019 Annual Meeting by attending Opsens’ complimentary educational symposium. The OptoWire features a large nitinol core with excellent torque response and […]
